Medicare Enrolled

Dr. Stephen Makoni, MD

Hematology & Oncology · Lake Worth, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
3450 LANTANA RD STE 100, Lake Worth, FL 33462
5619651864
In practice since 2006 (19 years)
NPI: 1073544532 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Makoni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Makoni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Makoni

Dr. Stephen Makoni is a hematology & oncology in Lake Worth, FL, with 19 years in practice. Based on federal Medicare data, Dr. Makoni performed 4,513 Medicare services across 1,182 unique beneficiaries.

Between the years covered by Open Payments, Dr. Makoni received a total of $32,420 from 88 pharmaceutical and/or device companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Makoni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 29% volume in FL$ $32,420 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,513
Medicare services
Top 29% in FL for hematology & oncology
1,182
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~238 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Epoetin alfa injection (Procrit) for anemia1,640$6$20
Complete blood count (CBC) with differential510$8$24
Blood draw (venipuncture)444$8$12
Infusion, normal saline solution, 250 cc343$1$7
Office visit, established patient (30-39 min)339$96$150
Comprehensive metabolic blood panel166$10$38
Hospital follow-up visit, high complexity140$97$150
Initial hospital admission, high complexity124$143$280
Drug injection, under skin or into muscle106$11$45
Ferritin level test (iron stores)101$13$47
Iron level test101$6$30
Transferrin (iron binding protein) level101$12$40
Administration of chemotherapy into vein, 1 hour or less95$104$270
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less63$49$155
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional56$16$32
Vitamin B-12 level test45$15$55
Folic acid level test45$14$32
New patient office visit (45-59 min)35$125$215
Office visit, established patient, complex (40-54 min)35$142$200
Lactate dehydrogenase (enzyme) level13$6$15
New patient office visit, complex (60-74 min)11$162$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
40.8% medium
50.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$32,420
Total received (2018-2024)
Avg $4,631/year across 7 years
Top 19% in FL for hematology & oncology
88
Companies
663
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,858 (42.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,603 (38.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,959 (18.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,062
2023
$6,379
2022
$3,197
2021
$4,347
2020
$3,520
2019
$1,269
2018
$8,645

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Exelixis Inc.
$4,976
AbbVie, Inc.
$4,906
AstraZeneca Pharmaceuticals LP
$4,179
GlaxoSmithKline, LLC.
$2,081
TAIHO ONCOLOGY, INC.
$1,858
BeiGene USA, Inc.
$1,529
Daiichi Sankyo Inc.
$1,095
PFIZER INC.
$848
Janssen Biotech, Inc.
$835
Merck Sharp & Dohme LLC
$684
Novartis Pharmaceuticals Corporation
$667
E.R. Squibb & Sons, L.L.C.
$607
Celgene Corporation
$595
GENZYME CORPORATION
$539
Sirtex Medical Inc
$413
Incyte Corporation
$412
Seagen Inc.
$380
Lilly USA, LLC
$370
Takeda Pharmaceuticals U.S.A., Inc.
$339
Merck Sharp & Dohme Corporation
$289
ABBVIE INC.
$243
Eisai Inc.
$235
Genentech USA, Inc.
$234
Dova Pharmaceuticals
$230
Astellas Pharma US Inc
$214
Amgen Inc.
$197
Pharmacyclics LLC, An AbbVie Company
$194
Boehringer Ingelheim Pharmaceuticals, Inc.
$185
Penumbra, Inc.
$141
JAZZ PHARMACEUTICALS INC.
$135
Sobi, Inc
$135
Progenics Pharmaceuticals, Inc.
$127
EMD Serono, Inc.
$124
ARRAY BIOPHARMA INC
$113
Janssen Scientific Affairs, LLC
$113
Puma Biotechnology, Inc.
$107
Karyopharm Therapeutics Inc.
$99
Ipsen Biopharmaceuticals, Inc
$97
Mirati Therapeutics, Inc.
$90
Bayer HealthCare Pharmaceuticals Inc.
$88
Bayer Healthcare Pharmaceuticals Inc.
$81
Regeneron Healthcare Solutions, Inc.
$78
EISAI INC.
$72
Alexion Pharmaceuticals, Inc.
$72
Integra LifeSciences Corporation
$64
Kyowa Kirin, Inc.
$63
TerSera Therapeutics LLC
$58
MorphoSys, US Inc.
$57
Abbott Laboratories
$56
Global Blood Therapeutics, Inc.
$55
PUMA BIOTECHNOLOGY, INC.
$55
Jazz Pharmaceuticals Inc.
$47
Myriad Genetic Laboratories, Inc.
$46
Pharmacosmos Therapeutics Inc.
$45
Janssen Pharmaceuticals, Inc
$43
ImmunoGen, Inc.
$43
SOBI, INC
$43
Mylan Institutional Inc.
$41
Alnylam Pharmaceuticals Inc.
$41
Kite Pharma, Inc.
$39
AbbVie Inc.
$37
Rigel Pharmaceuticals, Inc.
$37
Agios Pharmaceuticals, Inc.
$36
Organon LLC
$33
ADC Therapeutics America, Inc.
$33
SHIELD THERAPEUTICS INC
$28
Pharmacyclics LLC, an AbbVie Company
$28
PharmaEssentia USA Corporation
$26
Fennec Pharmaceuticals, Inc.
$24
Deciphera Pharmaceuticals Inc.
$23
Octapharma USA, Inc.
$22
Fortovia Therapeutics, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$21
TG Therapeutics, Inc.
$20
Epizyme, Inc.,
$20
Advanced Accelerator Applications
$19
Apellis Pharmaceuticals, Inc.
$19
Clovis Oncology, Inc.
$19
Ethicon Inc.
$18
Novo Nordisk Inc
$17
RECORDATI_RARE_DISEASES_INC.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Aveo Pharmaceuticals, Inc.
$16
AMAG Pharmaceuticals, Inc.
$16
Adaptive Biotechnologies Corporation
$15
Emmaus Medical, Inc.
$15
Seattle Genetics, Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 43.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · AUGTYRO · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Indigo System · Integra · JAKAFI · JEMPERLI · JETI PERIPHERAL CATHETER · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Novoeight · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PYLARIFY · PYRUKYND · Pedmark · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYLVANT · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (43%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $718 per 100 Medicare services performed
Looking for a hematology & oncology in Lake Worth?
Compare hematology & oncologys in the Lake Worth area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
40
Per 100K population
2.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Makoni is a mixed practice specialist, with above-average Medicare volume (top 29% in FL), and high industry engagement (consulting-driven, top 19%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Makoni experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Makoni performed 1,640 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Makoni receive payments from pharmaceutical companies?
Yes. Dr. Makoni received a total of $32,420 from 88 companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Makoni's costs compare to other hematology & oncologys in Lake Worth?
Dr. Makoni's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Makoni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →